DividendChannel.com

Commit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using Options

By Dividend Channel Staff, Wednesday, April 17, 11:39 AM ET

Investors considering a purchase of Bio-Rad Laboratories Inc (NYSE:BIO) shares, but cautious about paying the going market price of $293.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $185 strike, which has a bid at the time of this writing of $1.00. Collecting that bid as the premium represents a 0.5% return against the $185 commitment, or a 1.3% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

Selling a put does not give an investor access to BIO's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $185 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Bio-Rad Laboratories Inc sees its shares fall 36.9% and the contract is exercised (resulting in a cost basis of $184.00 per share before broker commissions, subtracting the $1.00 from $185), the only upside to the put seller is from collecting that premium for the 1.3% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Bio-Rad Laboratories Inc, and highlighting in green where the $185 strike is located relative to that history:

The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the September put at the $185 strike for the 1.3% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Bio-Rad Laboratories Inc (considering the last 251 trading day closing values as well as today's price of $293.00) to be 35%. For other put options contract ideas at the various different available expirations, visit the BIO Stock Options page of StockOptionsChannel.com.


This Article's Word Cloud:   Arial   Below   Channel   Collecting   Investors   Laboratories   NYSE   Options   Puts   Selling   September   Start   Stock   StockOptionsChannel   YieldBoost   annualized   benefit   chart   considering   contract   exercised   fillColor   from   going   history   market   month   only   options   other   owning   premium   price   rate   represents   return   seller   selling   share   shares   strike   that   this   trading   trailing   twelve   upside   volatility   where   would

Commit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using Options | www.DividendChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.